-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Jingyou Pharmaceutical (00858.HK) issued an announcement. In order to achieve the division of responsibilities, meet the company's development needs, and raise the level of corporate governance, starting January 1, 2026: (1) Dr. Xie Yi will resign as CEO of the company to focus on formulating the company's strategy. Dr. Xie will continue to serve as Chairman of the Board and Executive Director after resigning as CEO; and (2) Dr. Guo Yi, the executive director, will be appointed as the Chief Executive Officer.

Zhitongcaijing·12/30/2025 12:17:06
Listen to the news
Zhitong Finance App News, Jingyou Pharmaceutical (00858.HK) issued an announcement. In order to achieve the division of responsibilities, meet the company's development needs, and raise the level of corporate governance, starting January 1, 2026: (1) Dr. Xie Yi will resign as CEO of the company to focus on formulating the company's strategy. Dr. Xie will continue to serve as Chairman of the Board and Executive Director after resigning as CEO; and (2) Dr. Guo Yi, the executive director, will be appointed as the Chief Executive Officer.